Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Queensland Health
Farmers Insurance

Generated: August 21, 2019

DrugPatentWatch Database Preview

Patent: 8,685,381

  Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,685,381
Title:Topical base and active agent-containing compositions, and methods for improving and treating skin
Abstract: The invention provides skin protecting and penetrating, easy-to-administer base and active agent-containing compositions, such as those including hydrocortisone, for treating the skin of mammals for different dermatologic disorders. This is effected by topically administering effective amounts of the compositions thereto in forms that address the skin and mucosa of the mouth and lips, and the rest of the body. Additionally, an optional flavoring addition to these products affords significantly better tasting, and less bitter, compositions, allowing a more pleasant experience and better compliance by patients. The compositions include a unique formulation of FANCOL VB, Natunola Castor 1023, Finsolv TN, bees wax and, optionally, one or a plurality of plant or plant seed oils, fatty alcohols, fats and flavorings, in desirable weight percents thereof, in various forms, and preferably in a form of a solid roll-on stick in a variety of sizes and of a jar or pot.
Inventor(s): Schlessinger; Joel (Omaha, NE), Schlessinger; Daniel Isaac (Omaha, NE)
Application Number:13/233,012
Patent Claims:see list of patent claims

Details for Patent 8,685,381

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merz Pharms XEOMIN incobotulinumtoxina INJECTABLE; INJECTION 125360 002 2010-07-30   Try a Free Trial 2030-10-23 RX search
Merz Pharms XEOMIN incobotulinumtoxina INJECTABLE; INJECTION 125360 001 2010-07-30   Try a Free Trial 2030-10-23 RX search
Ipsen Biopharm Ltd DYSPORT abobotulinumtoxina INJECTABLE; INJECTION 125274 002 2009-04-29   Try a Free Trial 2030-10-23 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.